Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Neoplasms 2Uterine Cervical Neoplasms 1Respiratory Aspiration 1Pain 1Ovarian Neoplasms 1Meningioma 1Hemorrhage 1Esophageal Neoplasms 1Endometrial Neoplasms 1Disease 1Breast Self-Examination 1Breast Neoplasms 1

Interventions

Cisplatin 160Fluorouracil 134Paclitaxel 125Radiotherapy 117Oxaliplatin 87Carboplatin 71Docetaxel 70Irinotecan 59pembrolizumab 57Capecitabine 57Leucovorin 56Radiation 47Surgical Procedures, Operative 33Drug Therapy 33Esophagectomy 31Cetuximab 25Neoadjuvant Therapy 24Nivolumab 23Bevacizumab 21Trastuzumab 20camrelizumab 19S 1 (combination) 19Chemoradiotherapy 17Albumin-Bound Paclitaxel 16Magnetic Resonance Spectroscopy 15Epirubicin 15tislelizumab 14Taxes 13Radiotherapy, Intensity-Modulated 13Cyclophosphamide 13

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Esophageal Neoplasms × Sensitivity Training Groups × Clear all
NCT02335970 2020-01-06

Effects of a Training Intervention After Thoracoabdominal Oesophagus Surgery

Göteborg University

Phase NA Completed
64 enrolled
Gastrointestinal

Esophageal Neoplasms, Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡